Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 3 49-3, 2001, Pages

  Olsson, M Charlotte ^a   Palmer, Bradley M ^a   Leinwand, Leslie A ^a,b   Moore, Russell L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Diastolic; Isovolumic; Myosin; Systolic

Indexed keywords

ACTIN BINDING PROTEIN; MYOSIN HEAVY CHAIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; FEMALE; GENDER; GENE MUTATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HYPERTROPHIC CARDIOMYOPATHY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLE; TRANSGENIC MOUSE;

EID: 0034973172     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.3.h1136     Document Type: Article

References (24)

1. Gender differences in older patients with pressure-overload hypertrophy of the left ventricle
2. Comparison of clinical findings in idiopathic dilated cardiomyopathy in women versus men
3. Evaluation of cardiac structure and function in two mouse models of familial hypertrophic cardiomyopathy
4. Progression from hypertrophic to dilated cardiomyopathy in mice that express a mutant myosin transgene
5. A mouse model of familial hypertrophic cardiomyopathy
6. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation
7. A transgenic rabbit model for human hypertrophic cardiomyopathy
8. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1)
9. Sudden cardiac death in hypertrophic cardiomyopathy
10. Implications of left ventricular remodeling in hypertrophic cardiomyopathy
11. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy
12. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy
13. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: Assessment with thallium-201 emission computed tomography
14. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy
15. Left ventricular chamber dilation in hypertrophic cardiomyopathy: Related variables and prognosis in patients with medical and surgical therapy
16. 403/+ mouse model of familial hypertrophic cardiomyopathy
17. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilation in hypertrophic cardiomyopathy
18. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy
19. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis
20. Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
21. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy
22. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
23. Low power, type II errors, and other statistical problems in recent cardiovascular research
24. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy